MCC
CPRX

Money Concepts Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Money Concepts Capital’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233K Buy
+9,430
New +$225K 0.01% 511
2023
Q1 		– Sell
-400
Closed -$7.44K – 948
2022
Q4 		$7.44K Buy
400
+173
+76% +$2.66K ﹤0.01% 2168
2022
Q3 		$3K Buy
+227
New +$2.69K ﹤0.01% 1303

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Money Concepts Capital's CPRX Position: Q1 2026 in Review

Money Concepts Capital opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 9,430 shares worth $233K. The stake represents 0.01% of the portfolio and ranks #511 among its holdings. This is a return to the name: Money Concepts Capital previously reported a position in CPRX as recently as Q4 2022.

Money Concepts Capital first reported a position in CPRX in Q3 2022 and has held it in 3 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Money Concepts Capital held 9,430 shares of Catalyst Pharmaceutical worth $233K as of Q1 2026.
  • Catalyst Pharmaceutical was a new Money Concepts Capital position in Q1 2026.
  • Catalyst Pharmaceutical made up 0.01% of Money Concepts Capital's portfolio in Q1 2026, its #511 holding.
  • Money Concepts Capital first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 3 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Money Concepts Capital's 13F filing for Q1 2026, filed 30 Apr 2026.